A miracle. In October 2022, Ben Trotman learned that he suffers from a glioblastoma when he is only 40 years old. This malignant brain tumor is the most common in adults. “”The glioblastomas develop along the fibrous pathways of the brain and thus spread locally, regionally and supragionally. As a rule, glioblastomas do not cause metastases outside the nervous system“, Details the University Hospital of Bern.
Read also >> “Could I attend my son’s second anniversary?” : At 42, just dad, he thinks that his headache is caused by stress, he actually suffers from “Terminator cancer”
“Receiving this diagnosis was the most traumatic experience. We were struggling with the fact that Ben had gone from apparently perfect health to live“, says Emily, his wife. He then becomes the only patient in the world to integrate a clinical trial on ipilimab, an immunotherapy medication. Marketed under the name of Yervoy, this monoclonal antibody stimulates the immune system so that he recognizes and attacks cancer cells, explains the New York Post. chemotherapy.
“The tumor has not returned”
“The crucial element of this test is that the patient’s immune system is strengthening thanks to the drug. They can then take another treatment when they are in good shape and healthy to tolerate immunotherapy“Explains Dr. Paul Mulholland, the medical oncologist consultant who heads the test. Two years and eight months later, the results of his scanners are clear.”It is very unusual to have a clear scanner with a glioblastoma, especially when he has not undergone the follow -up operation which had been planned to remove the whole tumor initially visible on the scanners“confirms Dr. Paul Mulholland.
Today, the 43 -year -old father no longer presents a sign of tumor. “”We found that Ben, the only patient recruited for the Neat-Glio immunotherapy study, had clear scanners since treatment and that the tumor had not returned more than two and a half years later.“
An upcoming new test
In January 2023, a few months after his diagnosis, Ben married Emily. The couple welcomed a little girl whom they like to take a walk with their rescue dog.
Read also >> This strange symptom in terms of the nose was the first sign of fatal cancer, doctors give him a year to live
For the rest, the researchers plan to recruit 16 patients with glioblastoma over a period of 18 months. “”I am delighted that this new test, with the same immunotherapy medication that I have received, continues and that other people have the opportunity to participate. This will give people who recently diagnosed with a glioblastoma.“